As part of New York Climate Week, LanzaJet's CEO addressed the President of the Republic of Kazakhstan and met with…
Through Week 56 in the SOLARIS trial, there were no suspected or confirmed post-injection delirium/sedation syndrome (PDSS) events observed with…
September 20, 2025 11:00 ET | Source: C4 Therapeutics, Inc. Cemsidomide in Combination With Dexamethasone Achieved a 50% Overall Response…
Oral semaglutide 25 mg (the once-daily pill formulation of Wegovy®) achieved significant weight loss, with one in three study participants…
17 September 2025 - With just 70 days to go until the Olympic flame is lit in Olympia, Greece, the International…
SKY-0515 achieves dose-dependent reductions of mutant huntingtin (mHTT) protein, with 62% lowering at Day 84 on the 9mg daily oral…
HTL0039732 (also known as NXE0039732) is Nxera’s novel oral EP4 antagonist being investigated to treat a wide range of solid…
Former Amadeus President and Southwest Airlines SVP & CIO Join Payment Orchestration Leader to Drive Next Phase of Travel Retailing…
Supply chain planning veteran brings technical expertise, experience scaling go-to-market functions to lead company through next phase of growth WILMINGTON,…
Genesis Magma Racing’s technical leads reflect on the busy first weeks of the GMR-001 Hypercar’s on-track development phase FX Demaison and…